Fortem Financial Group’s Corvus Pharmaceuticals CRVS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-11,000	Closed	-$19.6K	–	171
2024 Q1	$19.6K	Buy	+11,000	New	+$19.6K	0.01%	165